Why the study?
The contribution of inherited thrombophilic mutations to hypercoagulability in patients with acquired thrombophilic conditions such as APS is not well understood.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
A 1968 study conducted a case report in Thrombosis / Antiphospholipid antibody syndrome (n=1). Inherited and acquired hypercoagulable conditions was evaluated on Extensive thrombosis and therapeutic response to anticoagulation.
Synapse has enriched 10 related papers. Consider them for comparative context: